Mercer Global Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.23M | Buy |
7,156
+840
| +13% | +$156K | ﹤0.01% | 1459 |
|
|
2025
Q4 | $1.26M | Buy |
6,316
+80
| +1% | +$14.5K | ﹤0.01% | 1334 |
|
|
2025
Q3 | $976K | Buy |
6,236
+3,223
| +107% | +$512K | ﹤0.01% | 1398 |
|
|
2025
Q2 | $457K | Buy |
3,013
+41
| +1% | +$5.47K | ﹤0.01% | 1609 |
|
|
2025
Q1 | $447K | Buy |
2,972
+521
| +21% | +$87.4K | ﹤0.01% | 1534 |
|
|
2024
Q4 | $452K | Sell |
2,451
-1,907
| -44% | -$367K | ﹤0.01% | 1504 |
|
|
2024
Q3 | $846K | Buy |
4,358
+327
| +8% | +$68K | ﹤0.01% | 1078 |
|
|
2024
Q2 | $833K | Buy |
4,031
+1,721
| +75% | +$390K | ﹤0.01% | 1052 |
|
|
2024
Q1 | $626K | Buy |
2,310
+210
| +10% | +$50.1K | ﹤0.01% | 1156 |
|
|
2023
Q4 | $497K | Buy |
2,100
+143
| +7% | +$28.1K | ﹤0.01% | 1333 |
|
|
2023
Q3 | $384K | Buy |
1,957
+287
| +17% | +$58.9K | ﹤0.01% | 1386 |
|
|
2023
Q2 | $351K | Sell |
1,670
-234
| -12% | -$46.6K | ﹤0.01% | 1414 |
|
|
2023
Q1 | $384K | Buy |
1,904
+230
| +14% | +$52.1K | ﹤0.01% | 1349 |
|
|
2022
Q4 | $365K | Sell |
1,674
-30
| -2% | -$6.55K | ﹤0.01% | 1390 |
|
|
2022
Q3 | $335K | Sell |
1,704
-77
| -4% | -$16.6K | ﹤0.01% | 1343 |
|
|
2022
Q2 | $381K | Buy |
1,781
+223
| +14% | +$54.5K | ﹤0.01% | 1297 |
|
|
2022
Q1 | $442K | Sell |
1,558
-1,248
| -44% | -$385K | ﹤0.01% | 1292 |
|
|
2021
Q4 | $1.06M | Buy |
2,806
+583
| +26% | +$227K | 0.01% | 858 |
|
|
2021
Q3 | $917K | Sell |
2,223
-18
| -0.8% | -$7.48K | 0.01% | 896 |
|
|
2021
Q2 | $829K | Buy |
2,241
+1,485
| +196% | +$496K | 0.01% | 918 |
|
|
2021
Q1 | $219K | Buy |
+756
| New | +$210K | ﹤0.01% | 1441 |
|
Other funds holding CRL
VCM
VPM
